The FDA has granted 510(k) clearance to the TaviPilot AI software developed by Caranx Medical, according to company officials ...

Background Coarctation of the aorta (CoA) has good modern results, but large multicentre longitudinal data on outcomes, especially hospital resource utilisation through childhood and adolescence, are ...

MiRus announced new early feasibility study results supporting the use of its Siegel transcatheter aortic valve replacement ...

Transcatheter aortic valve implantation (TAVI) is now an established treatment option for elderly patients with severe ...

Traditional operative risk calculators, such as the European System for Cardiac Operative Risk Evaluation II (EuroSCORE II), ...

There is currently no way to stop calcification of the aortic valve. If all else fails, the valve must be replaced. To better ...

Edwards Lifesciences (NYSE: EW) announced today that the U.S. Food and Drug Administration (FDA) has approved its transcatheter aortic valve replacement (TAVR) therapy, the SAPIEN 3 platform, for ...

Surgical bioprosthetic aortic valves made with bioengineered Resilia tissue (Edwards Lifesciences) appear to suffer less structural deterioration over 8 years compared with similar devices made of ...

Edwards highlights 8-year durability data for its Resilia-equipped heart valves By Conor Hale Apr 18, 2025 11:30am Edwards Lifesciences heart valves TAVR transcatheter aortic valve replacement ...

CAIRO, April 18, 2025--Edwards Lifesciences (NYSE: EW) today announced new eight-year data showing that patients receiving aortic surgical valves treated with its proprietary RESILIA tissue ...

Edwards Lifesciences (NYSE: EW) today announced new eight-year data showing that patients receiving aortic surgical valves treated with its proprietary RESIL ...